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Objective: Sudden cardiac arrest caused by cardiac arrhythmias is 1 of the leading causes of death worldwide.
Implantable cardioverter defibrillators (ICDs) are considered as standard care for patients with increased risk
of arrhythmias. However, 1 in 4 ICD patients experiences psychological distress post-ICD implantation. The
WEB-based distress management program for ICD patients (WEBCARE) was developed to mitigate anxiety
and depression and enhance health-related quality of life in ICD patients. This study investigates the 6- and
12-months outcomes. Method: A total of 289 consecutive ICD patients from 6 referral hospitals in the
Netherlands were randomized to either the WEBCARE (n  146) or usual care (n  143) group. Patients in
the WEBCARE group received an online, 12-weeks fixed, 6 lesson behavioral treatment based on problem
solving therapy. Patients in the usual care group receive care as usual. Results: Current findings show no
significant difference on anxiety, depression or quality of life between the WEBCARE and Usual Care group
at 6- and 12-months postimplantation. Conclusions: In this clinical trial of a Web-based behavioral interven-
tion for ICD patients, the Web-based treatment was not superior to usual care on the long-term regarding
patient reported outcomes. Future studies are warranted to examine the applicability of blended-care models
and focus on further personalizing the program in order to increase adherence and improve outcomes.
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The implantable cardioverter defibrillator (ICD) is the treatment
of choice for the prevention of sudden cardiac death (Zipes et al.,
2006). The ICD is indicated for patients who have experienced a
sudden cardiac arrest (secondary prevention) and for patients who
have an increased risk to experience one in the future (primary
prevention) (Ezekowitz et al., 2007). The ICD monitors the heart
rate and is able to give an electric shock (up to 840 V) to the heart
muscle in case of life-threatening arrhythmias (Mirowski et al.,
1980). The experience of an electric shock has been described by
patients as “getting kicked in the chest by a big horse from the
inside out” (Adams, 2011). Despite its unpredictable nature, the
ICD is generally well accepted by the majority of patients (Ped-
ersen, Hoogwegt, Jordaens, & Theuns, 2013); however, one in four
patients experiences psychological distress postimplantation
(Magyar-Russell et al., 2011). Not only device-related concerns
(e.g., shock anxiety) and decreased quality of life (Morken et al.,
2012; Pedersen, van Domburg, Theuns, Jordaens, & Erdman,
2005), but also anxiety, depression, and posttraumatic stress have
been reported within the ICD population (Habibović, van den
Broek, Alings, Van der Voort, & Denollet, 2012; Magyar-Russell
et al., 2011; Rosman et al., 2015). In addition, an increasing
number of studies have demonstrated an association between psy-
chological distress and risk of tachyarrhythmia’s and mortality
despite state-of-the-art treatment with the ICD (Habibović, Peder-
sen, et al., 2013; Ladwig et al., 2008; Pedersen, Brouwers, &
Versteeg, 2012). Hence, it is of utmost importance to address
distress in these patients to provide the maximum benefits of the
ICD in terms of quality of life and survival.
In the last decades, intervention studies targeting anxiety and
depression in ICD patients have shown promising results (Dunbar
et al., 2012; Habibović, Burg, & Pedersen, 2013; Russell et al.,
2015). Especially the use of cognitive–behavioral therapy seems
to be effective in reducing anxiety and depression in ICD patients
(Habibović, Burg, et al., 2013). However, because of methodolog-
ical shortcomings of these studies (e.g., small sample sizes; high
drop-out; Salmoirago-Blotcher & Ockene, 2009), well-designed
studies with sufficient power are still warranted.
To reach a larger proportion of the ICD population and to reduce
the time and travel burden to patients (as compared to traditional
face-to-face treatment), we designed the WEB-based distress man-
agement program for implantable CARdioverter dEfibrillator pa-
tients (WEBCARE) with the objective of reducing distress (e.g.,
anxiety and depression) and improving quality of life (Pedersen et
al., 2009). The program was adapted from the existing Everything
Under Control (Alles Onder Controle) program developed to re-
duce distress in physically healthy patients by means of problem-
solving therapy (van Straten, Cuijpers, & Smits, 2008; Warmer-
dam, van Straten, Twisk, Riper, & Cuijpers, 2008). Patients were
encouraged to assess their problems and actively start working on
these using the problem-solving framework provided in the online
program. We have previously reported on the short-term effects of
the study, which showed no significant difference between the
WEBCARE and usual care group on psychological outcomes
(Habibović, Denollet, et al., 2014). The WEBCARE interven-
tion was set up as a preventive intervention to reduce the
number of patients experiencing distress on the long-term.
Hence, in the current study, we will evaluate the long-term
effects of WEBCARE, focusing on (a) psychological disease-
specific and generic outcome measures, and (b) which patients
benefit the most based on subgroup analyses stratified by base-
line distress, Type D personality, age, gender, number of les-
sons completed, and comorbidities.
Method
Participants
Consecutive ICD patients hospitalized between April 2010 and
February 2013 were recruited from six Dutch referral hospitals
(Amphia, Breda; Canisius-Wilhelmina, Nijmegen, Catharina,
Eindhoven; Erasmus Medical Center, Rotterdam; Onze Lieve
Vrouwe Gasthuis, Amsterdam; Vlietland, Schiedam). All patients
with a first-time ICD implant and aged between 18 and 75 years
were screened for study eligibility. Exclusion criteria were signif-
icant cognitive impairments (e.g., dementia), history of psychiatric
illness other than affective/anxiety disorders, life-threatening co-
morbidities (e.g., cancer), life expectancy 1 year, being on the
waiting list for heart transplantation, lack of Internet/computer
skills, and insufficient knowledge of the Dutch language.
Study Design
The WEBCARE study was a randomized controlled trial com-
prised of two study arms (intervention vs. usual care). Patients’
psychological functioning was assessed at four separate time
points (i.e., at baseline, 3-, 6-, and 12 months postimplantation)
using standardized and validated questionnaires. At baseline, pa-
tients’ medical records were screened to capture information on
clinical data. Based on a sample size calculation with a power of
.80 (two-tailed test), an alpha of .05, and an effect size of .30, 350
participants were required (175 in each condition) to demonstrate
an effect on the primary endpoint (symptoms of anxiety). A
detailed description of the trial design has been published else-
where (Pedersen et al., 2009).
Procedure
Prior to or briefly after ICD implantation, patients were ap-
proached for study participation by an ICD nurse or technician at
the implanting center. If they fulfilled all of the inclusion criteria
and none of the exclusion criteria, they were informed orally and
in writing about the study. Patients who were eligible and willing
to participate were requested to sign the informed consent and
were asked to complete a set of standardized questionnaires within
10 days postimplantation and return them in a prestamped enve-
lope to Tilburg University, which served as the core-lab for the
trial. If the questionnaires were not returned within 2 weeks,
patients received up to 3 reminder phone calls. For follow-up
assessment, the questionnaires were sent by mail to all patients
with the request to return the questionnaires within 7 days. If the
questionnaires were not returned within this timeframe, patients
received up to three reminder phone calls. The study was conducted
in accordance with the Helsinki declaration and approved by the
Medical Ethics Committees of the participating centers. WEBCARE
was registered on www.clinicaltrials.gov (NCT00895700). Study re-
sults are presented as advocated by the Consolidated Standards of
Reporting Trials guideline (Campbell, Piaggio, Elbourne, Altman, &






































































































2 HABIBOVIĆ ET AL.
Randomization
Patients were randomized on a 1:1 basis upon receipt of the
baseline questionnaires. Block randomization by computer was
used to randomize sets of 20 patients per hospital. The random-
ization list was generated by an independent, blinded statistician
and sealed by a research assistant. Prior to opening the envelope
containing the questionnaires, a sealed envelope containing the
condition (WEBCARE vs. Usual Care) was drawn for each pa-
tient. The health care providers were blinded to which condition
patients were assigned. Blinding participants and coaches was not
possible given the nature of the study.
Intervention
A detailed description of the intervention has been published
elsewhere (Habibović, Denollet, et al., 2014). In brief, patients
randomized to the WEBCARE condition received a 12-week fixed
six lesson online problem-solving training in addition to usual
care. The program was adapted from the Everything Under Control
treatment, which has previously been developed and evaluated
within a physically healthy population for treatment of depression
and anxiety (van Straten et al., 2008; Warmerdam et al., 2008).
The program consisted of six preprogrammed lessons starting with
psycho-education (Lesson 1) related to living with an ICD. In
Lessons 2 to 6, patients were required to make homework assign-
ments for which they received written personalized feedback via
the website from their coach. In Lesson 2, patients were required
to list the problems that they were experiencing at the moment and
to label them as either (a) important problems that can be solved,
(b) unimportant problems that can be solved, and (c) problems that
cannot be solved. In Lesson 3, patients were asked to choose one
of the important problems that can be solved and start working on
this problem using problem-solving skills (provided in the pro-
gram). In Lesson 4, “unimportant problems that can be solved”
were addressed and in Lesson 5 dealing with “problems that
cannot be solved” was discussed. Finally, in Lesson 6, patients
were asked to make a plan on how they plan to reach future goals.
Feedback was provided by master course students enrolled in a
2-year Medical Psychology degree program. As part of the degree
program, students were doing a clinical internship at a Dutch
hospital. Students received a specific standardized training about
providing online feedback. The program was amended to fit the
needs of ICD patients, providing them additional information
about living with an ICD, how to deal with shock anxiety (e.g.,
making a shock plan), and describing normal psychological prob-
lems associated with having an ICD. The WEBCARE group also
received a CD with relaxation exercises and was encouraged to use
it throughout the study. The control condition was care as usual.
Measures
Information on demographic variables were obtained by patient
self-report. Information on clinical data was captured from pa-
tients’ medical records. Patients’ psychological functioning was
assessed using standardized and validated questionnaires, both
generic and disease-specific.
Generic Outcome Measures
Anxiety. Anxiety was assessed using the seven-item General
Anxiety Disorder (GAD-7) Scale (Spitzer, Kroenke, Williams, &
Lowe, 2006). Items (e.g., “Feeling nervous, anxious, or on edge”)
were rated on a 4-point Likert scale ranging from 0 (not at all) to
3 (almost every day), with a total score range of 0–21. A cut-off
score of 10 was used to indicate probable clinical levels of
anxiety. The GAD-7 has a good internal consistency, as indicated
by Cronbach’s alpha of 0.92 (Spitzer et al., 2006) and has previ-
ously been used within the ICD population to assess anxiety
(Qintar et al., 2015).
Depression. Depression was assessed using the nine-item Pa-
tient Health Questionnaire (PHQ-9; Kroenke, Spitzer, & Williams,
2001). Items were (e.g., “Feeling down, depressed, or hopeless”)
evaluated on a 4-point Likert scale ranging from 0 (not at all) to 3
(almost every day), with a total score range of 0–21. A cut-off
score of 10 was used to indicate the presence of depressive
symptomatology. The PHQ-9 has a good validity (Kroenke et al.,
2001) and reliability, with a Cronbach’s alpha of .91(Dum, Pick-
ren, Sobell, & Sobell, 2008). The PHQ-9 has been validated within
the cardiac population showing a Cronbach’s alpha of .83 (Ham-
mash et al., 2013).
Quality of life. The Dutch version of the Short-Form Health
Survey 12 (SF-12) was administered to assess patients’ quality of
life (Ware, Kosinski, & Keller, 1996). The 12-item scale consists
of two components: Physical Component Summary (PCS) and
Mental Component Summary (MCS). The total score (on both
subscales) ranges between 0 and 100, with a higher score indicat-
ing better quality of life (Ware et al., 1996). The SF-12 has shown
to be a valid and reliable instrument within Dutch cardiac popu-
lations (Mols, Pelle, & Kupper, 2009).
Personality. Type D (distressed) personality was assessed
using the 14-item DS14 Scale (Denollet, 2005). The DS14 consists
of two seven-item subscales: negative affectivity (e.g., “I often feel
unhappy”) and social inhibition (e.g., “I am a closed kind of
person”). Items were answered on a 5-point Likert scale ranging
from 0 (false) to 4 (true), with a total score for each scale of 0–28
(Denollet, 2005). A cut-off score of 10 on both subscales indi-
cates a Type D personality. Both scales are internally consistent
with a Cronbach’s alpha of 0.88 for negative affectivity and 0.86
for social inhibition (Denollet, 2005).
Psychological Disease-Specific Outcome Measures
ICD related concerns. The Dutch version of the eight-item
ICD Patient Concerns (ICDC) Questionnaire was administered to
assess ICD related concerns (Pedersen et al., 2005). The ICDC taps
into fears about getting an ICD shock (e.g., “I am worried that my
ICD will fire”), with items rated on a 5-point Likert scale ranging
from 0 (not at all) to 4 (very much; Frizelle, Lewin, Kaye, &
Moniz-Cook, 2006). The total score range is 0–32, with a higher
score indicating higher levels of concerns. The ICDC is an inter-
nally consistent scale with a Cronbach’s alpha of 0.91 (Pedersen et
al., 2005).
Shock anxiety. Shock anxiety was assessed using the 10-item
Florida Shock Anxiety Survey (FSAS; e.g., “I worry about the ICD
firing and creating a scene”; Kuhl, Dixit, Walker, Conti, & Sears,
2006). Items were rated on a 5-point Likert scale ranging from 1






































































































3WEBCARE: DISTRESS MANAGEMENT FOR ICD PATIENTS
of shock anxiety. The FSAS is a reliable measure of ICD shock
anxiety, with a Cronbach’s alpha of 0.89 (Ford et al., 2012).
Device acceptance. The Florida Patient Acceptance Survey
(FPAS) was administered to assess device acceptance (Burns,
Serber, Keim, & Sears, 2005). Device acceptance has been de-
scribed as “psychological accommodation and the understanding
of the advantages and disadvantages of the device, the recommen-
dation of the device to others, and the derivation of benefits in
terms of biomedical, psychological, and social functioning” (Burns
et al., 2005). The 12-item (e.g., “I have returned to a full life”)
short version of the FPAS was used with items being answered
on a 5-point Likert scale ranging from 0 (strongly disagree) to
4 (strongly agree; Pedersen, Spindler, Johansen, Mortensen, &
Sears, 2008; Versteeg et al., 2012). The total score ranges
between 0 and 100, with a higher score indicating higher
acceptance. The FPAS has shown to be internally consistent
with a Cronbach’s alpha of 0.85 for the Dutch ICD population
(Versteeg et al., 2012).
Statistical Analyses
Continuous variables were compared using the Student’s t-test
for independent samples and are presented as mean values and
standard deviations. Discrete variables were compared using the 2
test and are presented as numbers and percentages. Analyses were
performed according to the intention-to-treat principle, with mean
imputation for missing item scores (if 80% of the items was
missing). In addition, multiple imputation with 20 iterations was
carried out for total score missings using the default option for
multiple imputation in SPSS 22.0.
To evaluate the treatment effectiveness over time, the linear
mixed models (LMM) procedure was performed. The LMM pro-
cedure is similar to linear regression analyses except that in LMM
the dependent variable is measured at multiple time points. These
analyses were all adjusted for baseline distress levels. If the inter-
action effects were not significant, the main effects only were
entered in the final model.
To examine whether the WEBCARE intervention had a differ-
ential impact on particular subgroups of patients, the LMM pro-
cedure was adapted evaluating the interaction effects between the
treatment condition and the subgroup variables of interest (base-
line distress score, Type D personality, age, gender, number of
lessons completed, and comorbidity burden as measured by Charl-
son’s Comorbidity Index). For these analyses, the Bonferroni
correction was applied, dividing alpha with the number of tests
conducted, with a statistically significant difference indicated at a
p value of 0.05/6  0.008 or lower.
All analyses were conducted with IBM SPSS Statistics for
Windows 22.0. For main analyses, a p value of .05 (two-tailed
test) was used to indicate statistical significance.
Results
Sample
Figure 1 shows a flowchart of the patient recruitment, including
patients lost to follow-up. A total of 1,024 patients were ap-
proached for participation, of which 492 (48%) did not meet the
inclusion criteria (lack of Internet, 53%; age 75, 30%; language
barrier, 6%). Of the remaining 532 patients, a total of 192 (36%)
refused to participate, and 51 (10%) did not return the baseline
questionnaire, leaving 289 patients that were randomized to
WEBCARE (n  146) versus usual care (n  143) group. A total
of 41 (28%) patients were lost to follow-up in the WEBCARE group
and 31 (22%) in the usual care group at 12 months follow-up.
Of the 146 patients randomized to the WEBCARE condition, 34
(23%) completed all six lessons of the online treatment. The
remaining 112 patients prematurely terminated the treatment due
to technical problems, time constraints, or lack of psychological
distress. No significant baseline differences were observed be-
tween treatment completers and drop-outs, a detailed description
of treatment adherence in WEBCARE has been published else-
where (Habibović, Cuijpers, et al., 2014).
Patients who did not return the baseline questionnaire (n  51)
did not differ significantly on demographic variables from patients
who were randomized. However, significant differences on clini-
cal variables were observed, with patients who were not random-
ized being more likely to have more severe heart failure, as
indicated by a higher New York Heart Association functional class
(p  .045) and peripheral artery disease (p  .001) and more
likely to use psychotropic mediation (p  .001).
Baseline Characteristics
A detailed overview of patients’ baseline characteristics has
been published elsewhere (Habibović, Denollet, et al., 2014). In
Table 1 an overview is provided of the sample characteristics. The
mean age of the sample was 58.5  9.9, with the majority of
patients being male (81%). Approximately half of the patients
were employed (49%) and 85% had a partner. Baseline differences
between the WEBCARE and usual care groups were observed
with respect to the proportion of patients having undergone a
percutaneous coronary intervention (usual care: 36% vs.
WEBCARE: 21%; p  .003) and using ACE-inhibitors (usual
care: 69% vs. WEBCARE: 56%; p  .03). No other systematic
baseline differences were observed between groups on psycho-
logical measures (Habibović, Denollet, et al., 2014).
Intervention Effects on Generic Outcome Measures
As displayed in Figure 2, no significant differences between the
WEBCARE and usual care group were observed on anxiety
(  .374; p  .23) and depression (  .085; p  .80). For
quality of life, two different patterns were observed. On the MCS
of the SF-12, no significant differences were observed (  .367;
p  .69), however, on the PCS a significant interaction effect
for Time 	 Condition was observed. This indicates that the PCS
scores tended to have a different pattern over time for the WEBCARE
versus usual care groups. Focusing on simple effects, no significant
differences between groups were observed at any measurement point
(T1:   .623; p  .57; T2:   .384; p  .74; T3:   1.647;
p  .15) on the PCS.
Intervention Effects on Psychological Disease Specific
Outcome Measures
On psychological disease specific outcomes no differences were






































































































4 HABIBOVIĆ ET AL.
shock anxiety (  .177; p  .90) or device acceptance
(  .024; p  .955) over time (Figure 3). These results indicate
that the WEBCARE treatment was not superior to usual care with
respect to decreasing device-related distress and increasing device
acceptance.
Subgroup Analyses
Subgroup analyses stratified by baseline distress, Type D per-
sonality, age, gender, and number of lessons completed showed no
significant treatment effects (results not shown) on any of the
outcome measures (neither generic nor disease specific). Patients
with a higher comorbidity burden as indicated by Charlson’s
Comorbidity Index reported increased scores on shock anxiety
(  0.847; p  .038) however, after Bonferroni correction, this
was no longer significant.
Discussion
This is the first study to evaluate the long-term effectiveness of
a fully Web-based behavioral treatment for ICD patients. Our
findings showed that the Web-based intervention was not superior
in reducing distress (generic and psychological disease-specific) or
increasing quality of life as compared to usual care. Generally, a
comparable decline in distress and increase in quality of life was
observed in both conditions over time. Subgroup analyses indi-
cated that patients with a higher comorbidity burden in the treat-
ment condition had somewhat increased shock anxiety, however,
this was not statistically significant.
Our findings are not in line with previously published results on
the effectiveness of the Everything Under Control intervention,
which the WEBCARE intervention was adapted from (van Straten
et al., 2008; Warmerdam et al., 2008). It is important to emphasize,
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5WEBCARE: DISTRESS MANAGEMENT FOR ICD PATIENTS
mentioned studies focused on a physically healthy population.
Despite the adaptations made to Everything Under Control to fit
patients with an ICD, it is possible that the intervention did not
succeed to meet the specific needs of these patients and should
have been more patient tailored. In addition, the current study
enrolled all patients regardless of their distress level at baseline, as
WEBCARE was designed as a prevention trial. Hence, a large
proportion of the patients did not experience any or low levels of
distress, leaving little room for improvement. Consequently, the
subgroup of patients with increased distress was perhaps too small
to detect any significant differences as compared to the nondis-
tressed patients, if present. Finally, in the current study patients
were approached for participation at the hospital, while in the trial
that evaluated the efficacy of the Everything Under Control inter-
vention, patients were recruited by means of self-selection (van
Straten et al., 2008; Warmerdam et al., 2008). The latter might
have resulted in a highly motivated sample of patients with severe
psychological distress who are willing to work on it (Kroenke,
2014).
As compared to other chronic patient populations engaged in
online treatment described in a previous study by Paul et al., the
current findings are in line with some, but not all studies (Paul,
Carey, Sanson-Fisher, Houlcroft, & Turon, 2013). Generally,
Web-based behavioral treatments for the chronically ill are prom-
ising with respect to improvements in psychological functioning
(Paul et al., 2013). A recent meta-analysis showed that the effects
of Web-based treatments in patients with somatic disease are
comparable to the effects of face-to-face treatment (Andersson,
Cuijpers, Carlbring, Riper, & Hedman, 2014). Hence, despite the
negative results of WEBCARE, it is important to continue to
develop and fine-tune Web-based treatment for the chronically ill,
as this might be a time- and money-saving approach to behavioral
treatment that is also patient-friendly in terms of patients accessing
treatment at a time that is suitable to them.
To advance the field of Web-based psychological interventions
for the chronically ill, there are several knowledge gaps that need
to be filled. Because of more intensive therapist involvement in
face-to-face treatment, associated costs are higher (McCrone et al.,
2004). There might also be a difference in drop-out rates in
face-to-face versus Web-based interventions. Drop-out rate in
face-to-face behavioral interventions in cardiac patients is mostly
related to time and travel burden (Habibović, Burg, et al., 2013),
whereas drop-out in the Web-based treatments tends primarily to
be related to technical problems (Habibović, Cuijpers, et al., 2014).
Introducing a treatment that combines personal contact (e.g., face-
to-face encounters and feedback) with Internet-based therapy (e.g.,
patient access in their own home at a time of their own conve-
nience)—blended care—might be a way forward to high-quality
and sustainable care (Wilhelmsen et al., 2013). However, it should
be noted that the subsequent costs associated with such an ap-
proach might be significantly higher due to an active involvement
of a coach/clinician. Another viable approach for future studies
Table 1







(n  143) p
Demographics
Age 58.5  9.9 58.2  9.9 58.6  10.2 .73
Gender (male) 235 (81.3) 120 (82.2) 115 (80.4) .70
Education (higha; n  285) 208 (73.0) 106 (73.1) 102 (72.9) .96
Working (yes; n  288) 141 (49.0) 68 (46.6) 73 (51.4) .41
Clinical
Secondary indication 90 (31.1) 39 (26.7) 51 (35.7) .10
Previous PCI 82 (28.4) 30 (20.5) 52 (36.4) .003
QRS  120 (n  287) 128 (44.6) 59 (41.0) 69 (48.3) .22
Heart failure 157 (54.3) 78 (53.4) 79 (55.2) .76
NYHA III/IV (n  232) 45 (19.4) 20 (17.4) 25 (21.4) .44
LVEF  35 184 (63.7) 87 (59.6) 97 (67.8) .15
Comorbidity
Diabetes 42 (14.5) 18 (12.3) 24 (16.8) .28
Hypertension 64 (22.1) 35 (24.0) 29 (20.3) .45
CCI 1.7  1.0 1.6  1.1 1.8  1.0 .15
Medication
Beta-blocker 237 (82.0) 117 (80.1) 120 (83.9) .40
ACE-inhibitor 180 (62.3) 82 (56.2) 98 (68.5) .03
Statins 182 (63.0) 92 (63.0) 90 (62.9) .99
Psychotropics 20 (6.9) 13 (8.9) 7 (4.9) .18
Psychological
Anxiety (n  288) 4.30  4.54 4.57  5.02 4.03  3.98 .31
Depression 5.65  4.83 5.93  5.11 5.37  4.53 .32
Quality of life
PCS 40.57  10.44 40.19  10.55 40.96  10.35 .53
MCS 44.29  11.08 43.83  11.28 44.76  10.89 .48
Note. PCI  percutaneous coronary intervention; QRS  QRS-Complex; NYHA  New York Heart
Association functional class; LVEF  left ventricular ejection fraction; CCI  Charlson Comorbidity Index;
PCS  Physical Component Summary (PCS); MCS  Mental Component Summary.






































































































6 HABIBOVIĆ ET AL.
would be to focus on the improvement of the technical and design
features of fully automated interventions. Improving these aspects
might contribute to higher adherence and could keep the associated
treatment costs to a minimum. Involving patients in the develop-
ment of the trial—also referred to as a user-centered design—or
having patients as a part of the treatment team, such that they are
actively involved during the intervention to support/guide the
patients who are participating in the treatment—might also en-
hance the success of the intervention (Yu et al., 2014). Treatment
should be tailored to the individual patient’s needs and prefer-
ences, as the “one-size fits all approach” is unlikely to work
(Habibović, Burg, et al., 2013). Furthermore, the appropriate tim-
ing and length of the treatment is still to be examined. Offering a
too-demanding treatment, too soon will most likely result in high
drop-out rates, influencing potential effects negatively (Habibović,
Burg, et al., 2013; Kroenke, 2014).
A number of study limitations must be acknowledged. First, the
intervention was offered within 2 weeks postimplantation. This
might have been too soon, as ICD patients are faced with several
challenges postimplant that include getting used to a life with a
device that can provide uncontrollable shocks, driving restrictions,
and concerns about how much they can and dare do with the ICD.
In addition, generally distress levels within the ICD population
decline within the first 3 months postimplant, representing adap-
tion to living with a device (Pedersen et al., 2013). Hence, it might
have been better if patients were monitored for distress the first 3
months and, if prevalent, offered the intervention. Second, we
assessed distress using validated and standardized self-report ques-
tionnaires rather than a clinical diagnostic interview. However,
some of the chosen measures (e.g., the ICDC and the HADS) have
been shown to predict mortality independent of traditional risk
factors in ICD patients, despite state-of-the-art treatment with the
ICD, and also to be sensitive to demonstrate treatment-related
effects (Mastenbroek, Versteeg, Jordaens, Theuns, & Pedersen,
2014; Pedersen, van den Broek, Erdman, Jordaens, & Theuns,
2010; Vazquez, Conti, & Sears, 2010). Third, we observed a
relatively high attrition and nonadherence rate during the interven-
tion and the study, although these rates are to some extent com-
parable to those found in other studies (van Straten et al., 2008;
Warmerdam et al., 2008) this might have negatively affected the
power of the study making it difficult to detect differences between
the groups.
In the current sample three main reasons for drop-out, as given
by patients, were technical problems with the computer, time
constraints, and “feeling fine” not having any problems to work on
(Habibović, Cuijpers, et al., 2014). In addition, patients who re-
fused to participate in the study but provided baseline medical
information appeared to have a higher disease severity burden than
patients who were enrolled in the study. Hence, this might have
contributed to the null findings as the patients who were enrolled
were relatively healthy and perhaps not in need of additional care.
These limitations might have reduced the ability of the current trial
to demonstrate significant treatment effects. Furthermore, as the
intervention was designed as a “one size fits all” prevention
approach, personalizing it to patients’ needs was not possible.
An important strength of the study is that the current sample
reflects the real-life uptake of a (preventive) Web-based interven-
tion, as it would be upon implementation in the health care system.
Patients were approached and included based on the relatively
broad inclusion criteria in a naturalistic setting. Hence, this reflects
the uptake of the intervention among the general ICD population.
The high attrition rates observed in the current study may thus
actually be a realistic representation of the intervention uptake
upon implementation.
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7WEBCARE: DISTRESS MANAGEMENT FOR ICD PATIENTS
In conclusion, we found no main treatment effect of WEBCARE
in ICD patients on generic and psychological disease-specific
measures of distress and quality of life 12 months’ postimplant nor
in subgroup analyses. Despite the negative results of WEBCARE,
and associated possible limitations of e-health interventions (e.g.,
high drop-out rates), it is advocated to focus on e-health solutions
as a viable options in ICD patients in particular and in patients with
cardiovascular disease in general as this might be a time- and
cost-effective approach. Further research is warranted to examine
which factors might contribute to treatment adherence (e.g., tech-
nical features/design of the intervention; human involvement).
E-Health solutions have many advantages, in particular that pa-
tients can do it in their own time and in their own home, thus
avoiding the stigma of seeing a mental health professional that is
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8 HABIBOVIĆ ET AL.
still present in the 21st century. Targeting distress in ICD patients
remains important due to the association of distress with premature
mortality in ICD patients despite state-of-the-art treatment with
ICD therapy.
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